Propylthiouracil (PTU) is a vital therapeutic agent utilized in the management of hyperthyroidism. This abstract delineates the systematic method development and validation process employing UV spectrometry for the quantification of PTU, ensuring its efficacy and safety in pharmaceutical formulations and biological samples.1 Validation of the UV spectrometric method encompassed a comprehensive assessment of key parameters such as linearity, accuracy, precision, specificity, and robustness. Calibration curves exhibited excellent linearity over a suitable concentration range, facilitating precise quantification of PTU in diverse matrices. The method demonstrated exceptional accuracy and precision, meeting the stringent criteria outlined in regulatory guidelines. 2The developed and validated UV spectrometric method offers a robust analytical approach for the quantification of PTU, providing pharmaceutical scientists and clinicians with a valuable tool for quality control assessments and pharmacokinetic studies. Its simplicity, cost-effectiveness, and accuracy underscore its utility in routine analysis, facilitating the timely and reliable determination of PTU concentrations in pharmaceutical formulations and biological samples, thereby enhancing patient care and treatment outcomes.